National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board
December 10, 2019 08:10 ET
|
Exagen, Inc.
SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen extends agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management
November 22, 2019 08:25 ET
|
Exagen, Inc.
SAN DIEGO, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Inc. Announces $26.2 Million Debt Refinancing
November 21, 2019 08:25 ET
|
Exagen, Inc.
SAN DIEGO, Calif., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen Inc. to Participate in the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019
November 20, 2019 05:15 ET
|
Exagen, Inc.
SAN DIEGO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Featured in Nine Scientific Presentations at 2019 ACR/ARHP Annual Meeting in Atlanta
October 28, 2019 08:15 ET
|
Exagen, Inc.
SAN DIEGO, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen to Be Honored with National Research Innovation Award by Lupus Foundation of America
October 21, 2019 08:15 ET
|
Exagen, Inc.
SAN DIEGO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE® Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing
October 15, 2019 08:15 ET
|
Exagen, Inc.
SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research
August 19, 2019 08:57 ET
|
Exagen Inc.
San Diego, CA and Albuquerque, NM, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers
April 24, 2019 09:55 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and their patients in the diagnosis, prognosis, and management of chronic...
JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors
March 26, 2019 08:45 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...